Free Trial

Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Up - Still a Buy?

Aveanna Healthcare logo with Medical background

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report)'s share price gapped up before the market opened on Monday . The stock had previously closed at $5.29, but opened at $5.56. Aveanna Healthcare shares last traded at $5.44, with a volume of 45,420 shares.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Truist Financial cut their price objective on Aveanna Healthcare from $6.00 to $5.25 and set a "hold" rating on the stock in a report on Monday, January 6th. UBS Group upped their price target on shares of Aveanna Healthcare from $3.20 to $4.50 and gave the company a "sell" rating in a report on Friday, March 14th.

View Our Latest Stock Analysis on AVAH

Aveanna Healthcare Stock Performance

The company has a fifty day moving average of $4.72 and a two-hundred day moving average of $4.96. The company has a market cap of $1.05 billion, a price-to-earnings ratio of -15.87 and a beta of 2.25.

Insider Buying and Selling

In related news, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $5.51, for a total transaction of $339,217.64. Following the transaction, the insider now owns 1,453,948 shares of the company's stock, valued at approximately $8,011,253.48. This trade represents a 4.06 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 7.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in AVAH. KLP Kapitalforvaltning AS purchased a new position in shares of Aveanna Healthcare in the fourth quarter valued at about $35,000. BNP Paribas Financial Markets purchased a new position in shares of Aveanna Healthcare during the fourth quarter valued at approximately $35,000. Tower Research Capital LLC TRC raised its stake in Aveanna Healthcare by 662.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after buying an additional 6,854 shares in the last quarter. Catalyst Funds Management Pty Ltd boosted its position in shares of Aveanna Healthcare by 321.4% in the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock worth $54,000 after purchasing an additional 9,000 shares in the last quarter. Finally, Sagespring Wealth Partners LLC bought a new position in Aveanna Healthcare in the 4th quarter worth about $57,000. Institutional investors own 87.96% of the company's stock.

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Read More

Should You Invest $1,000 in Aveanna Healthcare Right Now?

Before you consider Aveanna Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.

While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines